On Monday, Agilon Health Inc (NYSE: AGL) opened lower -1.41% from the last session, before settling in for the closing price of $5.68. Price fluctuations for AGL have ranged from $1.50 to $7.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 51.05% annually for the last half of the decade. Company’s average yearly earnings per share was noted 51.46% at the time writing. With a float of $301.50 million, this company’s outstanding shares have now reached $412.19 million.
In an organization with 1076 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -0.11%, operating margin of -4.77%, and the pretax margin is -4.11%.
Agilon Health Inc (AGL) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Agilon Health Inc is 26.87%, while institutional ownership is 71.64%. The most recent insider transaction that took place on Dec 13 ’24, was worth 55,085. In this transaction Director of this company bought 25,000 shares at a rate of $2.20, taking the stock ownership to the 73,166 shares. Before that another transaction happened on Dec 11 ’24, when Company’s Director bought 25,062 for $2.01, making the entire transaction worth $50,269. This insider now owns 66,144 shares in total.
Agilon Health Inc (AGL) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.77% during the next five years compared to 3.29% growth over the previous five years of trading.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Check out the current performance indicators for Agilon Health Inc (AGL). In the past quarter, the stock posted a quick ratio of 1.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Let’s dig in a bit further. During the last 5-days, its volume was 9.53 million. That was better than the volume of 5.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 78.27%. Additionally, its Average True Range was 0.43.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 89.52%, which indicates a significant increase from 78.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.30% in the past 14 days, which was higher than the 88.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.96, while its 200-day Moving Average is $3.78. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $5.77. Second resistance stands at $5.94. The third major resistance level sits at $6.11. If the price goes on to break the first support level at $5.43, it is likely to go to the next support level at $5.26. The third support level lies at $5.09 if the price breaches the second support level.
Agilon Health Inc (NYSE: AGL) Key Stats
There are currently 412,303K shares outstanding in the company with a market cap of 2.31 billion. Presently, the company’s annual sales total 6,061 M according to its annual income of -260,150 K. Last quarter, the company’s sales amounted to 1,522 M and its income totaled -105,790 K.
